Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vaginal pH and local metabolite environment constitute a dynamic physiological milieu essential for maintaining reproductive health and preventing infection. In healthy individuals of reproductive age, the vaginal pH is typically acidic, ranging from 3.8 to 4.5, a state primarily maintained by Lactobacillus species that ferment glycogen-derived glucose into lactic acid (StatPearls, 2023). This acidic environment, along with metabolites such as hydrogen peroxide and bacteriocins, serves as a primary innate immune barrier against the overgrowth of pathogenic bacteria and the acquisition of sexually transmitted infections (Amabebe & Anumba, 2018). When this balance is disrupted—a condition known as dysbiosis—the pH rises, and the metabolite profile shifts toward increased concentrations of biogenic amines and short-chain fatty acids, which are associated with bacterial vaginosis and adverse pregnancy outcomes (Borgdorff et al., 2016). Therapeutic strategies targeting this environment include the use of pH-buffering gels, such as Phexxi, and vaginal acidifiers like boric acid to restore the natural acidity (FDA, 2020). Additionally, probiotics and metabolic precursors are being explored to promote a stable, Lactobacillus-dominant environment as a preventative and curative measure for vaginal dysbiosis.
Restoration and maintenance of an acidic vaginal pH (3.5–4.5) to inhibit pathogen proliferation and support commensal microbial dominance through the delivery of exogenous acids or buffering agents (StatPearls, 2023; FDA, 2020).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal pH and local metabolite environment.